Prevalence and prognostic impact of frailty and its components in non-dependent elderly patients with heart failure
- PMID: 27072307
- DOI: 10.1002/ejhf.518
Prevalence and prognostic impact of frailty and its components in non-dependent elderly patients with heart failure
Abstract
Aims: The aim of this study was to evaluate the prevalence, clinical features, and the independent impact of frailty-a geriatric syndrome characterized by the decline of physiological systems-and its components, on prognosis after heart failure (HF) hospitalization.
Methods and results: FRAIL-HF is a prospective cohort study including 450 non-dependent patients ≥70 years old hospitalized for HF. Frailty was screened according to the biological phenotype criteria (low physical activity, weight loss, slow walking speed, weak grip strength, and exhaustion). The independent influence of frailty on mortality, functional decline, and readmission risks was calculated adjusted for HF characteristics and co-morbidities. Mean age was 80 ± 6 years; 76% fulfilled frailty criteria. Frail patients were older, more often female, but showed no differences in chronic co-morbidities, LVEF, and NT-proBNP levels. Slow walking speed was the most discriminative component between frail (89.2%) and non-frail patients (26%). Overall, 1-year survival was 89% in the non-frail group and 75% in frail subjects (P = 0.003). After adjusting for age, gender, chronic and acute co-morbidities, NYHA, and NT-proBNP, frail patients showed higher risks for 30-day functional decline [odds ratio (OR) 2.20, 95% confidence interval (CI) 1.19-4.08], 1-year all-cause mortality [hazard ratio (HR) 2.13, 95% CI 1.07-4.23], and 1-year readmission (OR 1.96, 95% CI 1.14-3.34). The association of individual components with 1-year adjusted mortality risk was HR 2.14, 95% CI 1.05-4.39 for low physical activity and HR 1.77, 95% CI 0.95-3.29 for slow walking speed.
Conclusion: Frailty is highly prevalent even among non-dependent elderly HF patients, and is an independent predictor of early disability, long-term mortality, and readmission. Individual frailty components may be useful for risk prediction.
Keywords: Frailty; Functional decline; Heart failure; Mortality; Readmission.
© 2016 The Authors. European Journal of Heart Failure © 2016 European Society of Cardiology.
Similar articles
-
Frailty Assessment in Advanced Heart Failure.J Card Fail. 2016 Oct;22(10):840-4. doi: 10.1016/j.cardfail.2016.02.003. Epub 2016 Feb 13. J Card Fail. 2016. PMID: 26883168
-
The frailty syndrome is associated with adverse health outcomes in very old patients with stable heart failure: A prospective study in six Spanish hospitals.Int J Cardiol. 2017 Jun 1;236:296-303. doi: 10.1016/j.ijcard.2017.02.016. Epub 2017 Feb 8. Int J Cardiol. 2017. PMID: 28215465
-
Competing Risk of Cardiac Status and Renal Function During Hospitalization for Acute Decompensated Heart Failure.JACC Heart Fail. 2015 Oct;3(10):751-61. doi: 10.1016/j.jchf.2015.05.009. JACC Heart Fail. 2015. PMID: 26449995
-
Impact of Frailty on Heart Failure Prognosis: Is Sex Relevant?Curr Heart Fail Rep. 2024 Apr;21(2):131-138. doi: 10.1007/s11897-024-00650-4. Epub 2024 Feb 16. Curr Heart Fail Rep. 2024. PMID: 38363515 Review.
-
Prognostic Value of Frailty for Older Patients with Heart Failure: A Systematic Review and Meta-Analysis of Prospective Studies.Biomed Res Int. 2018 Oct 22;2018:8739058. doi: 10.1155/2018/8739058. eCollection 2018. Biomed Res Int. 2018. PMID: 30426017 Free PMC article.
Cited by
-
Frailty in patients with acute decompensated heart failure in a super-aged regional Japanese cohort.ESC Heart Fail. 2021 Aug;8(4):2876-2888. doi: 10.1002/ehf2.13363. Epub 2021 Jun 3. ESC Heart Fail. 2021. PMID: 34080791 Free PMC article.
-
Impact of SGLT2 Inhibitors on Very Elderly Population with Heart Failure with Reduce Ejection Fraction: Real Life Data.Biomedicines. 2024 Jul 7;12(7):1507. doi: 10.3390/biomedicines12071507. Biomedicines. 2024. PMID: 39062080 Free PMC article.
-
Frailty and the risk of all-cause mortality and hospitalization in chronic heart failure: a meta-analysis.ESC Heart Fail. 2020 Dec;7(6):3427-3437. doi: 10.1002/ehf2.12827. Epub 2020 Sep 21. ESC Heart Fail. 2020. PMID: 32955168 Free PMC article. Review.
-
Age differences in contemporary treatment of patients with chronic heart failure and reduced ejection fraction.Eur J Prev Cardiol. 2019 Sep;26(13):1399-1407. doi: 10.1177/2047487319835042. Epub 2019 Mar 13. Eur J Prev Cardiol. 2019. PMID: 30866680 Free PMC article.
-
Frailty in Wild-Type Transthyretin Cardiac Amyloidosis: The Tip of the Iceberg.J Clin Med. 2021 Jul 31;10(15):3415. doi: 10.3390/jcm10153415. J Clin Med. 2021. PMID: 34362197 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous